Longterm Safety, Efficacy, and Inhibition of Structural Damage Progression Over 5 Years of Treatment With Abatacept in Patients With Rheumatoid Arthritis in the Abatacept in Inadequate Responders to Methotrexate Trial

Journal of Rheumatology- Canada

doi 10.3899/jrheum.130263

Full Text

Abstract

Available in

Date

Authors

Publisher

The Journal of Rheumatology


Related search